Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Saibil

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|May 6, 2020
Targeting T cell activation in immuno-oncologyS D Saibil, P S Ohashi
ESMO Open|March 20, 2025
How we treat patients with metastatic uveal melanomaE F Saldanha, M F Ribeiro, I Hirsch, et al.
Biochemical and Biophysical Research Communications|November 2, 1999
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cellsJ Tran, J Rak, C Sheehan, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumabS D Saibil, L Bonilla, H Majeed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
ESMO Open|November 16, 2024
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patientsS Genta, D V Araujo, K Hueniken, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|May 6, 2020
Targeting T cell activation in immuno-oncologyS D Saibil, P S Ohashi
ESMO Open|March 20, 2025
How we treat patients with metastatic uveal melanomaE F Saldanha, M F Ribeiro, I Hirsch, et al.
Biochemical and Biophysical Research Communications|November 2, 1999
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cellsJ Tran, J Rak, C Sheehan, et al.
Current Oncology (Toronto, Ont.)|July 10, 2019
Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumabS D Saibil, L Bonilla, H Majeed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
ESMO Open|November 16, 2024
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patientsS Genta, D V Araujo, K Hueniken, et al.
Pageof 1